全球紫杉醇注射液市场，依癌症类型、配销通路、地理位置。

Global Paclitaxel Injection Market, By Cancer Type, By Distribution Channel, By Geography .

出版日期: 2024年02月29日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年紫杉醇注射液市值为63.4亿美元，预计2031年将达到144.4亿美元，2024年至2031年年复合成长率（CAGR）为12.5%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	63.4 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	12.50%	2030/2031 价值预测：	144.4 亿美元

全球紫杉醇注射液市场占有率（%），按地区，2024年

由于癌症治疗的需求不断增加，紫杉醇注射液市场在过去几年中出现了显着增长。紫杉醇是一种用于化疗的有丝分裂抑制剂。它是在太平洋紫杉树的树皮中发现的。紫杉醇的作用是透过干扰微管的正常功能来阻止细胞分裂。在癌症治疗中施用时，紫杉醇可防止分裂中的癌细胞分离，进一步导致细胞死亡。该药物在对抗乳癌、卵巢癌、肺癌和后天免疫缺乏症候群（爱滋病）相关的卡波西氏肉瘤等多种癌症方面显示出令人鼓舞的结果。随着癌症盛行率的上升以及对含有紫杉醇注射液的化疗方案的日益依赖，预计市场在预测期内将稳定成长。

市场动态：

全球紫杉醇注射液市场受到乳癌和卵巢癌发生率上升的推动。根据世界卫生组织的数据，乳癌是女性最常见的癌症，全球每年新增病例超过 200 万例。此外，紫杉醇广泛用于治疗乳癌。此外，提高紫杉醇功效的先进技术进一步促进了市场成长。然而，替代治疗药物的可用性以及与紫杉醇注射相关的某些副作用是限制因素。开发奈米载体药物製剂以降低毒性并改善紫杉醇的输送为市场参与者带来了巨大的机会。

研究的主要特点：

该报告对全球紫杉醇注射液市场进行了深入分析，并提供了预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%），以2023年为基准年。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）介绍了全球紫杉醇注射市场的主要参与者。
本研究涵盖的主要公司包括百时美施贵宝公司、U & V Cancure Private Limited、辉瑞公司、绿叶製药集团、Fresenius Kabi AG、Accord Healthcare、Viatris Inc.、Teva Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd. 、Sandoz Group AG、Salvavidas、Sun Pharmaceutical Industries Ltd.、Cipla Inc.、Alvogen、Apotex Inc. 和Bharat Parenterals Limited。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球紫杉醇注射液市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球紫杉醇注射市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
澳洲
韩国
东协
亚太其他地区
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
南非
北非
中非

第 7 章：公司概况 - 全球紫杉醇注射剂市场

Bristol-Myers Squibb Company
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
U & V Cancure Private Limited
Pfizer Inc.
Luye Pharma Group
Fresenius Kabi AG
Accord Healthcare
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sandoz Group AG
Salvavidas
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Alvogen
Apotex Inc.
Bharat Parenterals Limited

第 8 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6704

The paclitaxel injection market is estimated to be valued at USD 6.34 Bn in 2024 and is expected to reach USD 14.44 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 6.34 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	12.50%	2030/2031 Value Projection:	US$ 14.44 Bn

Global Paclitaxel Injection Market Share (%), By Region, 2024

Global Paclitaxel Injection Market - IMG1

The paclitaxel injection market has witnessed significant growth in the past few years owing to its increasing demand in cancer treatment. Paclitaxel is a mitotic inhibitor used in chemotherapy. It was discovered in the bark of the Pacific Yew tree. Paclitaxel works by blocking cellular division through interfering with the normal functioning of microtubules. When administered in cancer treatment, paclitaxel prevents dividing cancer cells from separating, which further leads to cell death. The drug has shown encouraging results in fighting various types of cancers such as breast cancer, ovarian cancer, lung cancer, and Acquired Immune Deficiency Syndrome (AIDS)-related Kaposi's sarcoma. With the rising prevalence of cancer and increasing reliance on chemotherapy regimens containing paclitaxel injection, the market is expected to grow steadily over the forecast period.

Market Dynamics:

The global paclitaxel injection market is driven by the rising incidence of breast cancer and ovarian cancer. As per the World Health Organization, breast cancer is the most common cancer among women, with over 2 million new cases annually across the globe. Moreover, paclitaxel is extensively used in treating breast cancer. Additionally, advancing technologies for increasing the efficacy of paclitaxel are further augmenting the market growth. However, the availability of alternative treatment drugs and certain side-effects associated with paclitaxel injection are restraining factors. The development of nano-carrier drug formulations to reduce toxicity and improve paclitaxel delivery holds significant opportunities for market players.

Key Features of the Study:

This report provides an in-depth analysis of the global paclitaxel injection market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global paclitaxel injection market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Bristol-Myers Squibb Company, U & V Cancure Private Limited, Pfizer Inc., Luye Pharma Group, Fresenius Kabi AG, Accord Healthcare, Viatris Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sandoz Group AG, Salvavidas, Sun Pharmaceutical Industries Ltd., Cipla Inc., Alvogen, Apotex Inc., and Bharat Parenterals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global paclitaxel injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global paclitaxel injection market

Detailed Segmentation:

By Cancer Type:
- Breast Cancer
- Gastric Cancer
- Pancreatic Cancer
- Non-small Cell Lung Cancer
- Ovarian Cancer
- Kaposi sarcoma
- Others
By Distribution Channel:
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Bristol-Myers Squibb Company
- U & V Cancure Private Limited
- Pfizer Inc.
- Luye Pharma Group
- Fresenius Kabi AG
- Accord Healthcare
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Reddy's Laboratories Ltd.
- Sandoz Group AG
- Salvavidas
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- Alvogen
- Apotex Inc.
- Bharat Parenterals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Cancer Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
- Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition, and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Regulatory Scenario
Pricing Analysis
Product Recalls
Pipeline Analysis

4. Global Paclitaxel Injection Market, By Cancer Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Breast Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Gastric Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Pancreatic Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Non-small Cell Lung Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Ovarian Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Kaposi sarcoma, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Paclitaxel Injection Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Paclitaxel Injection Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

7. Company Profiles - Global Paclitaxel Injection Market

Bristol-Myers Squibb Company*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
U & V Cancure Private Limited
Pfizer Inc.
Luye Pharma Group
Fresenius Kabi AG
Accord Healthcare
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sandoz Group AG
Salvavidas
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Alvogen
Apotex Inc.
Bharat Parenterals Limited